05/27/2014 - 10:20am

Pfizer on Tuesday announced the introduction in the United States of over-the-counter Nexium 24HR, making the "Purple Pill" available for the treatment of frequent heartburn in adults.

05/23/2014 - 6:40pm

The Food and Drug Administration on Friday approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with acute bacterial skin and skin structure infections.

05/23/2014 - 12:42pm

Omnis Health recently announced the launch of EmbraceEVO, a new blood-glucose meter.

05/23/2014 - 9:48am

Teva Pharmaceutical on Friday announced that the Food and Drug Administration approved the use of QVAR (beclomethasone dipropionate HFA) with a dose counter for the treatment of asthma in patients 5 years of age and older.

05/22/2014 - 3:05pm

QS/1, a healthcare automation solutions provider, announced the release of an iPad app for signature capture.

05/21/2014 - 10:38am

Takeda Pharmaceutical on Tuesday announced that the Food and Drug Administration simultaneously approved a new biologic therapy, Entyvio (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease.

05/21/2014 - 10:06am

AsthmaMD recently launched its first retail product, the AsthmaMD Peak Flow Meter. The AsthmaMD Peak Flow Meter works with the newest AsthmaMD app and MyAsthmaMD secure cloud portal for physicians to help asthma patients more accurately track symptoms and medication adherence to preempt an attack.

05/16/2014 - 1:39pm

Pfizer announced plans to submit a new drug application with the Food and Drug Administration for palbociclib, which is used for the first-line systemic treatment of post-menopausal women with advanced or metastatic breast cancer.

05/16/2014 - 10:57am

The Food and Drug Administration on Thursday announced it required Sunovion Pharmaceuticals, manufacturer of the sleep drug Lunesta (eszopiclone), to change the drug label and lower the current recommended starting dose.